The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
Abstract
Objective Resistance to radiotherapy accounts for most treatment failures in cervical cancer patients who receive radical radiation therapy. To discover the possible mechanism of radioresistance and improve the 5-year survival rate, we focused on how sex-determining region Y-box 2 (SOX2) mediates radioresistance in cervical cancer as well as on the interaction between SOX2 and the hedgehog (Hh) signaling pathway in this study. Methods We established the acquired radioresistant subclone cells Hela-RR and Siha-RR. RT-qPCR, Western blot analysis, IHC, clonogenic survival assay, CCK-8 assay, apoptosis analysis, cell cycle analysis and xenograft models were used to explore the relationship between SOX2 expression and radiation resistance and to determine how SOX2 mediates radioresistance in cervical cancer. Furthermore, luciferase reporter and ChIP-PCR assays were utilized to assess the interaction between SOX2 and the Hh signaling pathway. Results Our research suggested that high expression of SOX2 was responsible for radioresistance in cervical cancer. SOX2 was observed to be closely related to irradiation-induced survival, proliferation, apoptosis, and cell cycle changes. The Hh signaling pathway was found to be activated in Hela-RR and Siha-RR, and the activation changed with SOX2 expression. IHC staining of SOX2 and Gli1 showed a close relationship between SOX2 and the Hh pathway. Luciferase reporter and ChIP-PCR assays demonstrated that SOX2 interacted with the Hh signaling pathway by occupying the HHAT promoter. Conclusions SOX2 is a potential therapeutic target of irradiation resistance in cervical cancer. It mediates radioresistance in cervical cancer via the Hh signaling pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, the efficacy of DNA damaging-based therapies is limited by toxicities and the acquisition of therapy resistance [3], particularly associated with a suboptimal regression during radiotherapy of CC patients [4].”
From Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer (2024) · cites this paper as [3]
Citations
Cites
Role of cell cycle in mediating sensitivity to radiotherapy
Pawlik, T. M., & Keyomarsi, K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.03.005 · Cited by 1,165
Clement, V., Sánchez‐Gómez, P., de Tribolet, N., Radovanovic, I., & Altaba, A. R. I. (2006) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,083
Eifel, P. J., Winter, K. A., Morris, M., Levenback, C., Grigsby, P. W., Cooper, J. S., Rotman, M. Z., Gershenson, D. M., & Mutch, D. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.197 · Cited by 1,018
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Bass, A. J., Watanabe, H., Mermel, C. H., Yu, S., Perner, S., Verhaak, R. G. W., Kim, S. Y., Wardwell, L., Tamayo, P., Gat‐Viks, I., et al. (2009) · Nature Genetics · doi:10.1038/ng.465 · Cited by 967
The Sox Family of Transcription Factors: Versatile Regulators of Stem and Progenitor Cell Fate
Sarkar, A., & Hochedlinger, K. (2013) · Cell stem cell · doi:10.1016/j.stem.2012.12.007 · Cited by 915
Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P., & Altaba, A. R. I. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900039 · Cited by 465
GLI transcription factors: Mediators of oncogenic Hedgehog signalling
Kasper, M., Regl, G., Frischauf, A., & Aberger, F. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.039 · Cited by 378
Sox2 promotes tamoxifen resistance in breast cancer cells
Piva, M., Domenici, G., Iriondo, O., Rábano, M., Simões, B. M., Comaills, V., Barredo, I., López‐Ruiz, J. A., Zabalza, I., Kypta, R. M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303411 · Cited by 328
Hussenet, T., Dali, S., Exinger, J., Monga, B., Jost, B., Dembélé, D., Martinet, N., Thibault-Carpentier, C., Huelsken, J., Brambilla, E. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008960 · Cited by 307
Justilien, V., Walsh, M. P., Ali, S. A., Thompson, E. A., Murray, N. R., & Fields, A. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.008 · Cited by 297
Research works printed but not linked: 3
- Kim, 2015, Clinical significance of OCT4 and SOX2 protein expression in cervical cancer, BMC Cancer, 15, 1015, 10.1186/s12885-015-2015-1 · DOI
- Nam, 2013, Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition, Cancer Res., 73, 4267, 10.1158/0008-5472.can-12-3516 · DOI
- Fang, 2011, The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis, BMC Genomics, 12, 11, 10.1186/1471-2164-12-11 · DOI
Cited by
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 669
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Khan, M. A., Κhan, P., Ahmad, A., Fatima, M., & Nasser, M. W. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.007 · Cited by 133
Huang, W., Zhang, L., Yang, M. Y., Wu, X., Wang, X., Huang, W., Lu, Y., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01878-x · Cited by 109
Self-citationMolecular landscape of recurrent cervical cancer
Adiga, D., Eswaran, S., Pandey, D., Sharan, K., & Kabekkodu, S. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103178 · Cited by 107
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
Mirzaei, S., Paskeh, M. D. A., Entezari, M., Mirmazloomi, S. R., Hassanpoor, A., Aboutalebi, M., Rezaei, S., Hejazi, E. S., Kakavand, A., Heidari, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113860 · Cited by 83
Gao, Z., Wang, Q., Ji, M., Guo, X., Li, L., & Su, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02872-9 · Cited by 57
Paskeh, M. D. A., Mirzaei, S., Gholami, M. H., Zarrabi, A., Zabolian, A., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., Aref, A. R., & Samarghandian, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112335 · Cited by 49
Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
Li, Z., Zhang, Y., Sui, S., Hua, Y., Zhao, A., Tian, X., Wang, R., Guo, W., Yu, W., Zou, K., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01737-1 · Cited by 48
Du, H., Zou, N., Zuo, H., Zhang, X., & Zhu, S. (2022) · FEBS Journal · doi:10.1111/febs.16681 · Cited by 38
Yao, T., Weng, X., Yao, Y., Huang, C., Li, J., Peng, Y., Lin, R., & Lin, Z. (2020) · BMC Cancer · doi:10.1186/s12885-020-07337-8 · Cited by 36
Self-citationFang, F., Guo, C., Zheng, W., Wang, Q., & Zhou, L. (2022) · Reproductive Sciences · doi:10.1007/s43032-021-00820-y · Cited by 36
The Roles of Hedgehog Signaling Pathway in Radioresistance of Cervical Cancer
Liu, C., & Wang, R. (2019) · Dose-Response · doi:10.1177/1559325819885293 · Cited by 35
MicroRNAs regulating SOX2 in cancer progression and therapy response
Mirzaei, S., Saebfar, H., Gholami, M. H., Hashemi, F., Zarrabi, A., Zabolian, A., Entezari, M., Hushmandi, K., Samarghandian, S., Aref, A. R., et al. (2021) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.15 · Cited by 29
Wang, S., Li, Z., Li, P., Li, L., Liu, Y., Feng, Y., Li, R., & Xia, S. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.75315 · Cited by 23
Cancer stem cells: Bridging microenvironmental interactions and clinical therapy
Wang, H., Li, J., Du, F., & Deng, H. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70406 · Cited by 22
Self-citationDownregulation of SOX2-OT Prevents Hepatocellular Carcinoma Progression Through miR-143-3p/MSI2
Hongfeng, Z., Bi, M., Lou, M., Yang, X., & Sun, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.685912 · Cited by 21
He, Y., Peng, X., Zheng, L., Tang, Y., Li, J., & Huang, X. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-533 · Cited by 20
Self-citationHazazi, A., Khan, F. R., Albloui, F., Arif, S., Abdulaziz, O., Alhomrani, M., Sindi, A. A. A., Abu-Alghayth, M. H., Abalkhail, A., Nassar, S. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155612 · Cited by 19
SOX2 and BCL-2 Expressions in Odontogenic Keratocyst and Ameloblastoma
Silva, B., Silva, L., Lima, K., dos Santos, A., Oliveira, A. D. P., Dezzen-Gomide, A., Batista, A. C., & Yamamoto-Silva, F. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23348 · Cited by 18
Zhang, H., Tan, M., Zhang, J., Han, X., & Ma, Y. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/2704753 · Cited by 16
Zhang, L., Guo, C., Ji, T., & Chen, X. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-020-03449-z · Cited by 16
RetractedHedgehog signaling and the glioma-associated oncogene in cancer radioresistance
Zhang, L., Zhang, Y., Li, K., & Xue, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1257173 · Cited by 15
PRKCI Mediates Radiosensitivity via the Hedgehog/GLI1 Pathway in Cervical Cancer
Wu, Z., Huang, C., Li, R., Li, H., Lu, H., & Lin, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887139 · Cited by 11
Self-citationTargeting Cervical Cancer Stem Cells by Phytochemicals
Tripathi, T., Yadav, J., Janjua, D., Chaudhary, A., Joshi, U., Senrung, A., Chhokar, A., Aggarwal, N., & Bharti, A. C. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673281823231222065616 · Cited by 11
SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis
Yuan, D., Wang, J., Yan, M., & Xu, Y. G. (2021) · The International Journal of Biological Markers · doi:10.1177/17246008211042899 · Cited by 11
CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
Yao, T., Yao, Y., Chen, Z., Peng, Y., Zhong, G., Huang, C., Li, J., & Li, R. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02573-3 · Cited by 10
Self-citationMyriad factors and pathways influencing tumor radiotherapy resistance
Mi, L., & Zhang, H. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0992 · Cited by 9
Wang, L., Zhang, X., Chen, S., Ye, Q., Basappa, B., Zhu, T., Lobie, P. E., & Pandey, V. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102103 · Cited by 8
“Neverthe-less, the efficacy of DNA damaging-based therapies is limited by toxicities and the acquisition of therapy resistance [3], particularly associated with a suboptimal regression during radiotherapy of CC patients [4].”
Lee, Y., Chien, P., Chang, Y., Huang, Y.-H., Chang, C.-F., Li, S.-T., & Chang, W. (2025) · Journal of Cancer · doi:10.7150/jca.111555 · Cited by 8
Afshar, S., Tapak, L., Amini, P., & Dinu, I. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18869 · Cited by 8
Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis
Sato, F., BHAWAL, U. K., Sugiyama, N., Osaki, S., Oikawa, K., & Muragaki, Y. (2020) · Clocks & Sleep · doi:10.3390/clockssleep2010004 · Cited by 7
Wu, N., Zhang, X., Zhu, M., Fang, C., Liu, X., Wang, Y., Li, H., Liu, S., Ting, H., Qin, C.-Z., et al. (2022) · Epigenetics · doi:10.1080/15592294.2022.2080995 · Cited by 7
Self-citationMiyachi, Y., Nishio, M., Otani, J., Matsumoto, S., Kikuchi, A., Mak, T. W., Maehama, T., & Suzuki, A. (2021) · Genes to Cells · doi:10.1111/gtc.12879 · Cited by 5
Seok, J., Ryu, C. H., Ryu, J., Kim, J. H., Lee, S.-J., Park, W. S., & Jung, Y. (2020) · Biology · doi:10.3390/biology9110387 · Cited by 4
Jia, Y., Yang, W., Tang, B., Feng, Q., & Dong, Z. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100979 · Cited by 4
Ren, J., Cai, J., & Wang, C. (2022) · Oncology Letters · doi:10.3892/ol.2022.13185 · Cited by 3
Primary impact of Gli1 on radioresistance in esophageal cancer
Yao, F., Yu, J., He, Y., Liu, J., Li, H., Liu, Q., Long, H., & Wu, Q. (2019) · Oncology Letters · doi:10.3892/ol.2019.10837 · Cited by 3
Hsa_circ_0084912 Drives the Progression of Cervical Cancer Via Regulating miR-429/SOX2 Pathway
Du, R., & Xiong, S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00701-6 · Cited by 3
The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential
He, Z., Hao, H., Li, X., Ji, Y., Zhao, K., Zhang, L., Jin, Y. C., & Wang, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1746979 · Cited by 2
Wang, T., Jiang, R., Tang, X., Yao, Y., & Jiang, P. (2025) · Acta Histochemica · doi:10.1016/j.acthis.2025.152230 · Cited by 1
Seth, A., Gupta, R. K., Nanda, S., Sonkar, P. K., Agarwal, S., Gupta, Y., & Shukla, A. K. (2026) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_395_25 · Cited by 1
Aurrekoetxea-Rodríguez, I. (2020) · Communities in ADDI (Universidad del Pais Vasco)
Huang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140230
Self-citationAdditional file 2 of Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
Li, Z., Zhang, Y., Sui, S., Hua, Y., Zhao, A., Tian, X., Wang, R., Guo, W., Yu, W., Zou, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13237450
Huang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140236
Self-citationHuang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140248
Self-citationHuang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140242
Self-citationHuang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140227
Self-citationHuang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140233
Self-citationHuang, W., Zhang, L., Yang, M., Wu, X., Wang, X., Huang, W., Yuan, L., Pan, H., Wang, Y., Wang, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14140245
Self-citationAdditional file 1 of Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
Li, Z., Zhang, Y., Sui, S., Hua, Y., Zhao, A., Tian, X., Wang, R., Guo, W., Yu, W., Zou, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13237447
la Cruz-Hernández, E. N. D., Morales‑Sandoval, G., Lizano, M., Avilés‐Salas, A., Castro-Muñoz, L. J., Carrillo‐García, A., Ramos‐Godínez, M. D. P., Coronel-Martínez, J. A., & Contreras‐Paredes, A. (2026) · Oncology Letters · doi:10.3892/ol.2026.15458
SOX2 promotes radiotherapy resistance in lung cancer via HSP70-mediated autophagy
Tong, J., Shi, Y., Xu, G., Dan, Y., Hu, B., Zhang, H., Xu, Q., & Liu, K. (2026) · European journal of medical research · doi:10.1186/s40001-026-04201-6
Tabanou, T. (2024) · theses.fr (ABES) · doi:10.70675/cccae35fz0b6fz472az9fcdza636abaf6c49
Molecular Biomarkers of Radiosensitivity and Radioresistance in Cervical Cancer: A Systematic Review
Girbovan, A. H., Balan, C., Kirsch-Mangu, A. T., Fischer‐Fodor, E., & Achimaș-Cădariu, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27157033
Metadata
- Authors
- Huang, C., Lu, H., Li, J., Xie, X., Fan, L., Wang, D., Tan, W., Wang, Y., Lin, Z., & Yao, T.
- Affiliations
- Sun Yat-sen University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- Corresponding author
- Lin, Zhongqiu
- Yao, Tingting
- ORCID
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 151
- Issue
- 3
- Pages
- 533-541
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2896784508
- Cited by
- 51
- References
- 38
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 17 · 2020: 10 · 2019: 2
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecologic Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81572575, 81602290)
- Guangdong Province Natural Scientific Grant (2014A030313109, 2016A020215059)
- Science and Technology Planning Project of Guangzhou (201601020102)
- Guangdong College Students' Innovation and Entrepreneurship Training Program (1055813194)
- National College Students' Innovation and Entrepreneurship Training Program (201310558097)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- SOX2, radioresistance (biology), cervical cancer, Hedgehog signaling, Gli1, apoptosis, cell cycle, therapeutic target
- MeSH terms
- Animals, Uterine Cervical Neoplasms, Female, Humans, Mice, Nude, Middle Aged, Signal Transduction, Hedgehog Proteins, SOXB1 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
